Home / KEEP BUT DO NOT DISPLAY / Alerts / FDA to Review Saxagliptin for Possible Heart Failure Risk

FDA to Review Saxagliptin for Possible Heart Failure Risk

Feb 14, 2014
1,668 views
 

FDA to Review Saxagliptin for Possible Heart Failure Risk

More to come in next week’s issue.